METLIFE INC
For the period ended Sep 30, 2026. Filed Nov 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 6, 2026
MET$102.44+0.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Interim Condensed Consolidated Balance Sheets
| September 30, 2026 | December 31, 2025 | |
|---|---|---|
| Assets | ||
| Investments: | ||
| Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of $185 and $249, respectively); and amortized cost: $351,670 and $337,201, respectively | $310,441 | $315,931 |
| Equity securities, at estimated fair value | 859 | 858 |
| Contractholder-directed equity securities and fair value option securities, at estimated fair value (includes $2,381 and $1,751, respectively, relating to variable interest entities) | 15,516 | 13,959 |
| Mortgage loans (net of allowance for credit loss of $1,521 and $1,193, respectively; includes $65 and $35, respectively, of mortgage loans held-for-sale) | 83,839 | 84,593 |
| Policy loans | 8,258 | 8,547 |
| Real estate and real estate joint ventures (includes $386 and $378, respectively, under the fair value option; $270 and $132, respectively, of real estate held-for-sale; $425 and $302, respectively, relating to variable interest entities) | 12,971 | 13,440 |
| Other limited partnership interests | 15,337 | 14,917 |
| Short-term investments, principally at estimated fair value | 7,879 | 3,601 |
| Other invested assets (includes $1,559 and $1,698, respectively, of leveraged and direct financing leases; $651 and $560, respectively, relating to variable interest entities) | 16,725 | 16,332 |
| Total investments | 471,825 | 472,178 |
| Cash and cash equivalents, principally at estimated fair value (includes $310 and $96, respectively, relating to variable interest entities) | 19,786 | 22,032 |
| Accrued investment income | 3,936 | 3,719 |
| Premiums, reinsurance and other receivables (includes $29 and $0, respectively, relating to variable interest entities) | 51,615 | 49,059 |
| Market risk benefits, at estimated fair value | 550 | 458 |
| Deferred policy acquisition costs and value of business acquired | 22,208 | 21,107 |
| Current income tax recoverable (includes $31 and $0, respectively, relating to variable interest entities) | 213 | 660 |
| Deferred income tax asset | 4,837 | 2,585 |
| Goodwill | 9,544 | 9,613 |
| Other assets | 11,134 | 11,822 |
| Separate account assets | 148,960 | 151,933 |
| Total assets | $744,608 | $745,166 |
| Liabilities, Mezzanine Equity and Equity | ||
| Liabilities | ||
| Future policy benefits | $199,120 | $208,855 |
| Policyholder account balances | 250,333 | 236,857 |
| Market risk benefits, at estimated fair value | 1,910 | 2,406 |
| Other policy-related balances | 20,947 | 20,070 |
| Policyholder dividends payable | 375 | 356 |
| Payables for collateral under securities loaned and other transactions | 18,500 | 17,115 |
| Short-term debt (includes $109 and $117, respectively, relating to variable interest entities) | 289 | 355 |
| Long-term debt (includes $57 and $28, respectively, relating to variable interest entities) | 14,301 | 14,467 |
| Collateral financing arrangement | 254 | 352 |
| Subordinated debt securities | 5,145 | 4,155 |
| Notes issued by collateralized financing entities (includes all amounts: under the fair value option; and relating to variable interest entities) | 1,940 | 1,206 |
| Deferred income tax liability | 301 | 536 |
| Other liabilities (includes $286 and $167, respectively, relating to variable interest entities) | 59,519 | 57,582 |
| Separate account liabilities | 148,960 | 151,933 |
| Total liabilities | 721,894 | 716,245 |
| Contingencies, Commitments and Guarantees (Note 18) | ||
| Mezzanine Equity | ||
| Redeemable noncontrolling interests | 195 | 241 |
| Equity | ||
| MetLife, Inc.’s stockholders’ equity: | ||
| Preferred stock, par value $0.01 per share; $2,905 aggregate liquidation preference | — | — |
| Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,196,987,977 and 1,195,587,190 shares issued, respectively; 631,106,615 and 655,333,773 shares outstanding, respectively | 12 | 12 |
| Additional paid-in capital | 32,964 | 32,858 |
| Retained earnings | 47,352 | 44,290 |
| Treasury stock, at cost; 565,881,362 and 540,253,417 shares, respectively | (32,798) | (30,678) |
| Accumulated other comprehensive income (loss) | (25,304) | (18,084) |
| Total MetLife, Inc.’s stockholders’ equity | 22,226 | 28,398 |
| Noncontrolling interests | 293 | 282 |
| Total equity | 22,519 | 28,680 |
| Total liabilities, mezzanine equity and equity | $744,608 | $745,166 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.